Works matching IS 14741776 AND DT 2010 AND VI 9 AND IP 12
Results: 26
Rare diseases, orphan drugs and their regulation: questions and misconceptions.
- Published in:
- 2010
- By:
- Publication type:
- review
Accelerating orphan drug development.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Hearing shines spotlight on biosimilar controversies.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 12, p. 905, doi. 10.1038/nrd3325
- By:
- Publication type:
- Article
The importance of new companies for drug discovery: origins of a decade of new drugs.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
In brief.
- Published in:
- 2010
- Publication type:
- Abstract
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 12, p. 899, doi. 10.1038/nrd3339
- Publication type:
- Article
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 12, p. 910, doi. 10.1038/nrd3338
- By:
- Publication type:
- Article
Targeting non-malignant disorders with tyrosine kinase inhibitors.
- Published in:
- 2010
- By:
- Publication type:
- journal article
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 12, p. 907, doi. 10.1038/nrd3337
- Publication type:
- Article
G protein-coupled receptors: Breathing easier with bitter tastes.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Thomas Lönngren.
- Published in:
- 2010
- Publication type:
- Interview
Trial watch: targeting IL-17A shows broad promise in autoimmune diseases.
- Published in:
- 2010
- Publication type:
- journal article
Vitamin D, disease and therapeutic opportunities.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Genomics drugs in clinical trials.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Strategic trends in the vaccine market.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 12, p. 913, doi. 10.1038/nrd3306
- By:
- Publication type:
- Article
Depression: In pursuit of happiness.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Deal watch: Recent trends in deal-making.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 12, p. 909, doi. 10.1038/nrd3329
- By:
- Publication type:
- Article
Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 12, p. 971, doi. 10.1038/nrd3295
- By:
- Publication type:
- Article
G protein-coupled receptors: Insights into chemokine receptors.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Drug delivery: Nanobioconjugate shrinks brain tumours.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Anticancer drugs: Expanding the horizons of PARP inhibitors.
- Published in:
- 2010
- By:
- Publication type:
- journal article
First oral warfarin alternative approved in the US.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Trial watch: success for crizotinib in ALK-driven cancer.
- Published in:
- 2010
- Publication type:
- journal article
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery.
- Published in:
- 2010
- By:
- Publication type:
- review
Vernakalant.
- Published in:
- 2010
- By:
- Publication type:
- journal article